We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHT
826
Universal Health Realty Income Trust
UHT
$626M
$202K 0.02%
4,413
-1,437
-25% -$61.8K
JOUT icon
827
Johnson Outdoors
JOUT
$502M
$201K 0.02%
5,564
-3,932
-41% -$145K
CATX icon
828
Perspective Therapeutics
CATX
$328M
$198K 0.02%
+14,843
New +$197K
SPOK icon
829
Spok Holdings
SPOK
$229M
$194K 0.02%
12,862
-4,160
-24% -$63.2K
OFIX icon
830
Orthofix Medical
OFIX
$497M
$193K 0.02%
12,384
-6,735
-35% -$108K
XPER icon
831
Xperi
XPER
$371M
$193K 0.02%
20,868
-3,482
-14% -$28.6K
CRCT icon
832
Cricut
CRCT
$987M
$192K 0.02%
+27,682
New +$166K
MCFT icon
833
MasterCraft Boat Holdings
MCFT
$608M
$191K 0.02%
10,503
-16,766
-61% -$319K
ERII icon
834
Energy Recovery
ERII
$435M
$189K 0.02%
10,890
-11,191
-51% -$177K
LEG icon
835
Leggett & Platt
LEG
$1.47B
$188K 0.02%
+13,803
New +$172K
MFIC icon
836
MidCap Financial Investment
MFIC
$806M
$186K 0.02%
+13,925
New +$197K
EXK
837
Endeavour Silver
EXK
$2.29B
$183K 0.02%
46,551
-19,754
-30% -$72.6K
MCW
838
DELISTED
Mister Car Wash
MCW
$183K 0.02%
+28,067
New +$190K
CTLP
839
DELISTED
Cantaloupe
CTLP
$182K 0.02%
24,547
+8,972
+58% +$61.6K
FDMT icon
840
4D Molecular Therapeutics
FDMT
$511M
$181K 0.02%
+16,787
New +$279K
SIBN icon
841
SI-BONE Inc
SIBN
$795M
$181K 0.02%
12,959
-3,059
-19% -$46K
APPS icon
842
Digital Turbine
APPS
$1.04B
$181K 0.02%
+58,843
New +$159K
RES icon
843
RPC Inc
RES
$1.16B
$178K 0.02%
+28,059
New +$177K
HAPN
844
Happen Inc
HAPN
$2.2B
$177K 0.02%
15,508
-634
-4% -$6.77K
OCSL icon
845
Oaktree Specialty Lending
OCSL
$1.05B
$176K 0.02%
+10,764
New +$184K
UIS icon
846
Unisys
UIS
$254M
$173K 0.02%
30,445
-34,177
-53% -$169K
JOBY icon
847
Joby Aviation
JOBY
$7.16B
$170K 0.02%
33,835
+5,584
+20% +$30.4K
OSUR icon
848
OraSure Technologies
OSUR
$276M
$168K 0.02%
39,305
-5,153
-12% -$22.1K
FATE icon
849
Fate Therapeutics
FATE
$274M
$163K 0.02%
46,631
-11,734
-20% -$45.7K
KW
850
DELISTED
Kennedy-Wilson Holdings
KW
$163K 0.02%
14,708
-4,690
-24% -$49.7K
32 33
34
35 36

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.